Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Halit Yerebakan is active.

Publication


Featured researches published by Halit Yerebakan.


Journal of Heart and Lung Transplantation | 2014

Continuous-flow left ventricular assist device exchange: Clinical outcomes

T. Ota; Halit Yerebakan; Hirokazu Akashi; Hiroo Takayama; Nir Uriel; P.C. Colombo; Urich P. Jorde; Yoshifumi Naka

BACKGROUNDnA percentage of patients with a left ventricular assist device (LVAD) require device exchange. Although this is an important clinical entity, there are only a handful of relevant studies on this topic in the literature.nnnMETHODSnFrom 2004 to 2012, 30 device exchanges (HeartMate II to HeartMate II) were performed. Since June 2011, we have employed the subcostal approach for device exchange if indicated. Sixteen patients underwent device exchange through a subcostal approach (S group), whereas 14 patients had devices exchanged through a full sternotomy (F group). Pre- and post-operative data were retrospectively reviewed.nnnRESULTSnThere was no difference in baseline patient characteristics between the two groups. Overall, mean duration between primary surgery and device exchange was 425 ± 407 days. Surgical indications included device thrombus/hemolysis (N = 19), device malfunction (N = 9) and infection (N = 2). Cardiopulmonary bypass time was significantly shorter in the S group (S: 40 ± 23 minutes, F: 105 ± 84 minutes; p < 0.05), and post-operative bleeding within 24 hours after surgery was less in the S group (S: 362 ± 367 ml, F: 1,286 ± 971 ml; p < 0.05). Length of ICU stay was significantly shorter in the S group (S: 4.6 ± 1.8 days, F: 8.2 ± 4.9 days; p < 0.05). There was no difference in post-operative complications, except for prolonged intubation (F: N = 6 [43%], S: N = 1 [6.3%]; p < 0.05). There were 3 deaths in the F group and 0 in the S group, with no statistical difference (p = 0.09). Also, there was no significant difference in other outcomes, including transplantation, device explantation and ongoing LVAD support.nnnCONCLUSIONSnA subcostal approach may be preferred for HeartMate II device exchange if indicated.


The Annals of Thoracic Surgery | 2015

Early complete atrioventricular canal repair yields outcomes equivalent to late repair

Elizabeth H. Stephens; Ali N. Ibrahimiye; Halit Yerebakan; Betul Yilmaz; Anjali Chelliah; Stéphanie M. Levasseur; Ralph S. Mosca; Jonathan M. Chen; Paul J. Chai; Jan Quaegebeur; Emile A. Bacha

BACKGROUNDnRepair of complete atrioventricular canal early in infancy has traditionally carried greater morbidity and mortality than repair performed later. However, an individualized anatomy-based repair may give young infants outcomes that are equivalent to older patients.nnnMETHODSnWe retrospectively reviewed 139 patients who underwent complete atrioventricular canal repair from January 2005 to December 2012. An individualized approach was used: 2-patch repair was performed in 98 patients for large ventricular septal defects and a modified single-patch (Australian technique) was used in 41 for shallow ventricular septal defects.nnnRESULTSnThe average age was 25.5 ± 3.9 weeks, 50% were boys, and 78% had trisomy 21. Mean follow-up was 5.1 ± 0.2 years, with 100% completeness of data. There were 3 in-hospital deaths (2.1%) and 1 late death (0.7%). A permanent pacemaker was required in 2 patients (1.4%). The rate for left atrioventricular valve reoperation was 8% at a mean of 211 ± 238 days after the original repair (range, 6 to 682 days). Compared with patients aged older than 3 months, the 39 patients (28%) who were younger than 3 months had similar perioperative courses and rate of reoperation. Compared with patients with an Australian repair, the 98 patients (71%) with a 2-patch repair were more likely to have trisomy 21 and had slightly increased cardiopulmonary bypass and cross-clamp times but similar outcomes. Multivariate analysis showed postoperative left atrioventricular valve regurgitation greater than 2 and left ventricular outflow tract obstruction were significant risk factors for reoperation on the left atrioventricular valve (both p < 0.05).nnnCONCLUSIONSnRepair of complete atrioventricular canal using an individualized surgical approach yields reoperation and early mortality rates similar for younger infants compared with older infants, obviating the need to delay operation in symptomatic patients.


Journal of the American College of Cardiology | 2013

TCT-758 Age Alone Should Not Preclude Surgery: Contemporary Outcomes after Aortic Valve Replacement in Nonagenarians

Halit Yerebakan; Isaac George; Bindu Kalesan; Tamim Nazif; Jacob Kriegel; Hiroo Takayama; Michael Argenziano; Yoshifumi Naka; Allan S. Stewart; Susheel Kodali; Craig R. Smith; Mathew Williams

A strong component of predicted mortality in scoring systems is advanced age, however, outcomes data in nonagenarians (age >90 years) is lacking. We evaluated surgical outcomes after aortic valve replacement (AVR) in nonagenarians at our institution over an 11-year period.nnDemographics, procedural


Journal of Heart and Lung Transplantation | 2014

Amiodarone Treatment Prior to Heart Transplantation Is Associated with Acute Graft Dysfunction and Early Mortality: A Propensity-Matched Comparison

Halit Yerebakan; Y. Naka; R. Sorabella; S.C. Hill; Koji Takeda; P.C. Schulze; Isaac George; M. Yuzefpolskaya; Maryjane Farr; Nir Uriel; P.C. Colombo; Ulrich P. Jorde; Donna Mancini; Hiroo Takayama


Japanese Circulation Journal-english Edition | 2015

Similar Survival in Patients Following Heart Transplantation Receiving Induction Therapy Using Daclizumab vs. Basiliximab

Spencer T. Martin; Tomoko S. Kato; Maryjane Farr; Jaclyn T. McKeen; Faisal H. Cheema; M. Ji; Alexandra Ross; Halit Yerebakan; Yoshifumi Naka; Hiroo Takayama; S. Restaino; Donna Mancini; P. Christian Schulze


Journal of the American College of Cardiology | 2014

DYNAMICS OF KIDNEY FUNCTION FOLLOWING AORTIC VALVE REPLACEMENT USING CKD-EPI BASED GFR ESTIMATION

Marc Najjar; Halit Yerebakan; Robert Sorabella; Maliha Hossain; Catherine Wang; Hiroo Takayama; Yoshifumi Naka; Mathew Williams; Michael Argenziano; Craig J. Smith; Isaac George


Journal of the American College of Cardiology | 2014

PRE-OPERATIVE RENAL DISEASE PROGRESSIVELY IMPACTS LONG-TERM SURVIVAL FOLLOWING AORTIC VALVE SURGERY

Halit Yerebakan; Robert Sorabella; Marc Najjar; Julie van Hassel; Catherine Wang; Hiroo Takayama; Yoshifumi Naka; Michael Argenziano; Mathew R. Wiliams; Craig J. Smith; Isaac George


Journal of Heart and Lung Transplantation | 2014

Reduced Long-term Outcomes after Orthotopic Heart Transplantation in Septuagenarians

Halit Yerebakan; R. Sorabella; M. Najjar; Estibaliz Castillero; V. Choi; Ulrich P. Jorde; Maryjane Farr; Donna Mancini; Y. Naka; Mathew S. Maurer; P.C. Schulze; Hiroo Takayama; Isaac George


Journal of Heart and Lung Transplantation | 2013

Long-Term Outcomes of Orthotopic Heart Transplantation in Patients with Cardiac Amyloidosis: Differential Survival by Amyloid Type

Halit Yerebakan; A. Castano; T. Ota; Isaac George; L. Hwang; Sophie Jones; C. Ryus; S. Naroji; J. Alvarez; Y. Naka; Hiroo Takayama; Mathew S. Maurer


Journal of Heart and Lung Transplantation | 2013

Increasing Heart Donation: Results of a Multi-Ethnic Population-Based Survey from Turkey

Halit Yerebakan; Sophie Jones; E. Blotky; T. Ota; E. Kaya; Z.T. Demirozu; M.A. Ozatik; C. Yakut; M. Ozbaran; D.S. Kucukaksu

Collaboration


Dive into the Halit Yerebakan's collaboration.

Top Co-Authors

Avatar

Hiroo Takayama

Columbia University Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

P.C. Schulze

Columbia University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Y. Naka

Columbia University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Donna Mancini

Icahn School of Medicine at Mount Sinai

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

M. Ji

Columbia University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Faisal H. Cheema

Columbia University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Maryjane Farr

Columbia University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Yoshifumi Naka

Columbia University Medical Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge